CACI International Inc (NYSE:CACI) announced today that its Board of Directors has authorized the repurchase of up to $750 million of its common stock.
Adamis Pharmaceuticals Changes Name To DMK Pharmaceuticals To Reflect New Strategic Focus; Company’s Common Stock Is Expected To Trade Under The New Nasdaq Ticker Symbol “DMK” On Or About September 8, 2023
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a commercial-stage biopharmaceutical company, today announced the company changed its name to DMK Pharmaceuticals Corporation in order to better reflect its new
